Back to User profile » Professor Emmanuel Obeagu
Papers published by Professor Emmanuel Obeagu:
Hematologic Glyco-Signatures: Emerging Blood-Based Sugar Codes Linked to Hyper-Aggressive Breast Cancer
Obeagu EI
Breast Cancer: Targets and Therapy 2026, 18:603801
Published Date: 1 May 2026
Novel Microbiome-Driven Approaches to Counteract Chemotherapy-Induced Mucositis in Breast Cancer Patients
Obeagu EI
Breast Cancer: Targets and Therapy 2026, 18:590718
Published Date: 19 February 2026
Strategies to Safeguard Mental Health Among Medical and Allied Health Trainees: A Narrative Review
Obeagu EI
Advances in Medical Education and Practice 2025, 16:2219-2227
Published Date: 2 December 2025
Clear Cell Ovarian Carcinoma and Its Distinct Coagulopathy Profile: Molecular Drivers and Clinical Implications
Obeagu EI
Cancer Management and Research 2025, 17:2459-2467
Published Date: 27 October 2025
Hypoxia, Inflammation, and Cytokine Crosstalk in Sickle Cell Disease: From Mechanisms to Modulation- A Narrative Review
Obeagu EI
Pediatric Health, Medicine and Therapeutics 2025, 16:217-225
Published Date: 27 August 2025
N2 Neutrophils and Tumor Progression in Breast Cancer: Molecular Pathways and Implications
Obeagu EI
Breast Cancer: Targets and Therapy 2025, 17:639-651
Published Date: 23 July 2025
Advancing Leukemia Diagnosis and Treatment: WHO-Supported Laboratory Innovations in Africa- A Narrative Review
Obeagu EI
Blood and Lymphatic Cancer: Targets and Therapy 2025, 15:47-67
Published Date: 24 June 2025
Modulation of Chronic Cytokine Dysregulation in Cervical Cancer: Potential Biomarkers and Therapeutic Targets
Obeagu EI
Cancer Management and Research 2025, 17:1113-1126
Published Date: 13 June 2025
Telomere Dynamics in Sickle Cell Anemia: Unraveling Molecular Aging and Disease Progression
Obeagu EI, Obeagu GU
Journal of Blood Medicine 2024, 15:313-323
Published Date: 26 July 2024
Eosinophils and Cognitive Impairment in Schizophrenia: A New Perspective
Obeagu EI, Bluth MH
Journal of Blood Medicine 2024, 15:227-237
Published Date: 21 May 2024
